If your cycles have been unpredictable for years, your weight sits stubbornly around your middle, and "just lose weight" is the only advice you've gotten, you're not imagining a metabolic thread connecting it all. The useful move isn't more willpower—it's actually looking at what's going on.

When weight and cycle changes travel together

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions in people of reproductive age, affecting an estimated 6–13% depending on the criteria used, and it is frequently underdiagnosed [1]. It's typically defined by some combination of irregular or absent ovulation, signs of elevated androgens (like acne or unwanted hair growth), and polycystic-appearing ovaries on ultrasound [2]. But the part that often goes unexamined is metabolic: a large share of people with PCOS also have insulin resistance, where the body has to produce more insulin to keep blood sugar steady [2][3].

That matters because insulin isn't only a blood-sugar hormone. Higher circulating insulin can nudge the ovaries to produce more androgens and can lower the protein (sex hormone–binding globulin, or SHBG) that normally keeps androgens in check—leaving more active androgen in circulation [3]. The result can look like the picture many people describe: irregular cycles, acne, and weight that concentrates around the abdomen rather than evenly.

This is educational information, not medical advice, and PCOS is a clinical diagnosis only an independent licensed provider can make after evaluation.

PCOS at a glance
6–13%Affected (reproductive age)depending on criteria used
UnderdiagnosedOftenper WHO fact sheet

Source: [1] Polycystic ovary syndrome (PCOS) — Fact sheet

Why the waist specifically

Abdominal (visceral) fat is metabolically active and is associated with insulin resistance and higher cardiometabolic risk—independent of overall body size [4]. That's part of why waist-focused weight can feel uniquely stubborn and why it's a pattern providers pay attention to rather than dismiss. It also explains a frustrating loop: insulin resistance can make weight harder to shift, and excess central weight can in turn worsen insulin resistance [3][4].

The point isn't that something is "wrong with you." It's that the standing-shift fatigue, the relentless late-day cravings, and the midsection weight may share an upstream driver worth measuring directly.

What a provider may actually look at in labs

Instead of guessing, an independent provider may order bloodwork to understand the metabolic and hormonal picture together. Commonly considered markers in this space include:

  • Fasting glucose and A1c — a window into how the body is handling blood sugar over time [5].
  • Fasting insulin — to gauge whether the body is overproducing insulin to keep glucose normal [3].
  • Androgens (e.g., total and free testosterone) and SHBG — relevant when acne or cycle irregularity are present [2][3].
  • Lipids — because central adiposity and insulin resistance often travel with changes in cholesterol and triglycerides [4].

These values are interpreted in context—your history, your cycle pattern, your symptoms—not in isolation. The goal of testing is a real explanation, not a label slapped on without data.

A1c reference categories (ADA)
Normal 5.7Prediabetes 6.5Diabetes range 8

% A1c · marker = Diabetes threshold

Source: [5] Standards of Care in Diabetes—2024: Classification and Diagnosis (American Diabetes Association)

Where GLP-1 medications enter the conversation

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. GLP-1 receptor agonists are a class of medications that act on that pathway; they influence blood-sugar regulation and signals involved in appetite and fullness [6][7]. Two molecules often discussed are semaglutide and tirzepatide (tirzepatide acts on both GIP and GLP-1 receptors) [6][7]. They are prescription medications carrying FDA-labeled warnings and possible side effects—including gastrointestinal effects and a boxed warning regarding thyroid C-cell tumors observed in rodents—which is exactly why they require provider evaluation and monitoring [6][7].

Why would a provider consider this class when the picture looks PCOS-adjacent? Because the same insulin-resistance biology that can drive central weight is part of what these medications act on metabolically. A provider weighing this isn't treating "a number on a scale"—they're considering whether a metabolism-focused approach fits the underlying pattern your labs reveal, alongside nutrition, sleep, and movement.

Important framing, with no promises: a prescription is never guaranteed. Whether any medication is appropriate is decided by an independent licensed provider based on your evaluation, history, and labs—and some people aren't candidates.

"I'd rather start with oral options"

That's a reasonable preference to bring to a visit. Metabolic care in this space can involve oral medications as well as injectables, and the right starting point depends on your evaluation. Some longevity-oriented programs also offer compounded formulations.

Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. A provider is the right person to discuss whether an oral or other route is suitable for you—this article does not recommend any specific drug or route.

What monitoring tends to look like

When weight and hormonal markers overlap, follow-up usually isn't "start and forget." A provider may re-check relevant labs over time, track tolerability and side effects, and reassess whether the plan still fits. The aim is a picture that improves on the inside—glucose handling, androgen-related symptoms, energy—not just a single number. Pacing and any dose decisions are the provider's role, not something to self-manage from an article.

If cycle regularity is a goal, that's also a provider conversation, since several factors influence it and PCOS management is individualized [1][2].

From questions to a coordinated plan
1MeasureLabs: glucose, A1c, insulin, androgens, SHBG, lipids
2EvaluateIndependent provider reviews history + results
3DecideProvider determines if any treatment fits
4MonitorRe-check labs, tolerability, and fit over time

Source: [2] International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023, [5] Standards of Care in Diabetes—2024: Classification and Diagnosis (American Diabetes Association)

Bringing it back to you

If you've been told to "just lose weight" without anyone checking your labs, the more productive path is the reverse: measure first, then decide. Real bloodwork can turn a vague sense that your metabolism is "working against you" into specific, discussable data—and give an independent provider something concrete to evaluate, including whether a metabolism-focused plan (oral or otherwise) makes sense for your situation.

You deserve to be looked at, not dismissed.

Where Velri fits

Velri is a technology and coordination company—not a medical practice. We help coordinate lab work and connect you with an independent, licensed provider who reviews your history and results and decides, independently, whether any treatment is appropriate. If a provider prescribes, the medication is dispensed by an independent licensed pharmacy. Velri doesn't provide medical care, doesn't guarantee any prescription, and doesn't promise outcomes. This article is educational and is not medical advice; please consult a licensed provider about your individual situation.